Immunicon

Immunicon Corporation (NASDAQ IMMC) was a Huntingdon Valley, Pennsylvania biotechnology company that pioneered immunomagnetic cell-selection technology for isolating and characterizing rare circulating tumor cells (CTCs) from blood. It developed the CellSearch and CellTracks diagnostic platforms, licensed to Veridex, LLC (a Johnson & Johnson company) for oncology use. Immunicon filed for Chapter 11 bankruptcy in 2008 and was acquired by Veridex/Johnson & Johnson; the CellSearch platform later passed to Menarini Silicon Biosystems. The company was backed by Canaan Partners and publishes no public API or developer surface.

Immunicon is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Diagnostics, Oncology, and Medical Devices.

🌐 Visit website 📡 Source on GitHub
2.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiotechnologyDiagnosticsOncologyMedical DevicesLife SciencesDefunct

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 2.2/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 0.0 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/immunicon: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Source (apis.yml)

apis.yml Raw ↑ 
aid: immunicon
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/immunicon.png
name: Immunicon
description: Immunicon Corporation (NASDAQ IMMC) was a Huntingdon Valley, Pennsylvania biotechnology company that pioneered
  immunomagnetic cell-selection technology for isolating and characterizing rare circulating tumor cells (CTCs) from blood.
  It developed the CellSearch and CellTracks diagnostic platforms, licensed to Veridex, LLC (a Johnson & Johnson company)
  for oncology use. Immunicon filed for Chapter 11 bankruptcy in 2008 and was acquired by Veridex/Johnson & Johnson; the CellSearch
  platform later passed to Menarini Silicon Biosystems. The company was backed by Canaan Partners and publishes no public
  API or developer surface.
url: https://raw.githubusercontent.com/api-evangelist/immunicon/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Diagnostics
- Oncology
- Medical Devices
- Life Sciences
- Defunct
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence